Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.535 USD | -1.53% | -6.36% | -28.87% |
05-10 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
05-10 | PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.87% | 130M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- Oppenheimer Adjusts PDS Biotechnology Price Target to $23 From $24, Maintains Outperform Rating